Literature DB >> 26126151

Congenital Lung Lesion: Prenatal Course, Therapy and Predictors of Perinatal Outcome.

Bernhard Stoiber1, Ueli Moehrlen2, Jouzas Kurmanavicius1, Martin Meuli2, Christian Haslinger1, Roland Zimmermann1, Nicole Ochsenbein1.   

Abstract

Purpose To describe the prenatal course and perinatal outcome, and to define prognostic markers for fetuses with congenital pulmonary airway malformation (CPAM) or bronchopulmonary sequestration (BPS). Materials and Methods A retrospective study was performed at the University Hospital Zurich including pregnancies with either fetal CPAM (n = 26) or BPS (n = 11) between 2000 and 2013. Results Three patients decided for termination of pregnancy. Two intrauterine deaths (CPAM) occurred at 25 weeks. Minimally invasive interventions were performed in 9/37 (24 %) fetuses, post-interventional survival was 8/9 (89 %). Mean gestational age at delivery was 38.1 +/-2.8 and 39.1 +/-2.5 weeks in fetuses with CPAM or BPS, respectively. In fetuses with CPAM the perinatal mortality rate was 4/24 (17 %); the rate of invasive interventions or surgery during the early neonatal period (neonatal morbidity) was 9/22 (41 %). Prenatal diagnosis of hydrothorax and/or increasing cystic volume ratio (CVR) until delivery preceded perinatal death in 3/5 (60 %). Absent mediastinal shift showed a neonatal morbidity rate of 1/8 (13 %) without any perinatal mortality. In fetuses with BPS the perinatal morbidity and mortality were both 1/10 (10 %). Hydrops predicted morbidity and mortality in 100 % of cases. Absent hydrops was followed by uncomplicated perinatal outcome. Conclusion Fetuses with CPAM or BPS have a good outcome under optimal perinatal care including the possibility to perform minimally invasive prenatal interventions. CPAM without mediastinal shift and BPS without hydrops have an excellent prognosis. Hydrothorax, increasing CVR or hydrops indicates a high risk for perinatal morbidity and mortality. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2015        PMID: 26126151     DOI: 10.1055/s-0035-1553261

Source DB:  PubMed          Journal:  Ultraschall Med        ISSN: 0172-4614            Impact factor:   6.548


  6 in total

1.  Computer-aided quantitative MSCT measurements may be useful for congenital lung malformations surgical approach selection.

Authors:  Weili Yang; Cong Shen; Nan Yu; Youmin Guo; Weikang Pan; Peng Li; Ya Gao; Xin Chen; Jiwen Cheng
Journal:  Pediatr Surg Int       Date:  2021-07-02       Impact factor: 1.827

Review 2.  Diagnostic value of congenital pulmonary airway malformation volume ratio for fetal hydrops due to congenital lung malformations: a systematic review and meta-analysis.

Authors:  Pei Zhu; Kaisheng Cheng; Mingsheng He; Yutong Wang; Pengyue Shen; Kanglin He; Chang Xu; Ben Zhang; Zhenmi Liu
Journal:  Orphanet J Rare Dis       Date:  2022-06-03       Impact factor: 4.303

3.  Bronchopulmonary Sequestration with Morbid Neonatal Pleural Effusion despite Successful Antenatal Treatment.

Authors:  Natalie Divjak; Sabine Vasseur Maurer; Eric Giannoni; Yvan Vial; Anthony de Buys Roessingh; Barbara E Wildhaber
Journal:  Front Pediatr       Date:  2017-12-04       Impact factor: 3.418

4.  Clinicopathological features of resected pediatric congenital lung and mediastinal lesions: A single institution experience.

Authors:  Saud A Al Jadaan; Suliaman M Alaqeel; Nouf Alsadoun; Noor H Allababidi; Majed Alharbi; Alaa S Almuzaini; Marya Alsuhaibani; Abdulrahman Alsulaiman
Journal:  Saudi Med J       Date:  2021-02       Impact factor: 1.484

5.  Prenatal Diagnosis and Evaluation of Sonographic Predictors for Intervention and Adverse Outcome in Congenital Pulmonary Airway Malformation.

Authors:  Astrid Hellmund; Christoph Berg; Annegret Geipel; Meike Bludau; Andreas Heydweiller; Haitham Bachour; Andreas Müller; Annette Müller; Ulrich Gembruch
Journal:  PLoS One       Date:  2016-03-15       Impact factor: 3.240

6.  Management Options for Fetal Bronchopulmonary Sequestration.

Authors:  Magdalena Litwinska; Ewelina Litwinska; Krzysztof Szaflik; Marzena Debska; Tomasz Szajner; Katarzyna Janiak; Piotr Kaczmarek; Miroslaw Wielgos
Journal:  J Clin Med       Date:  2022-03-20       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.